Surgical Antibiotic Prophylaxis Use in Pediatric and Adolescent Ovarian Surgery: A NSQIP-Pediatric Analysis.

Authors

Erica C Arnold, Yueran Zhang, Geri Hewitt, Kyle J Van Arendonk, Jennifer H Aldrink, Sara A Mansfield

Published in

Journal of pediatric surgery. Pages 163380. Aug 12, 2026. Epub Aug 12, 2026.

Abstract

The American College of Obstetricians and Gynecologists recommends avoidance of surgical antibiotic prophylaxis (SAP) for laparoscopic ovarian procedures. However, these recommendations exclude patients <18 years old. This study aims to understand SAP use in pediatric ovarian surgery and its association with surgical site infection (SSI).
Perioperative SAP details and SSI rates from the National Surgical Quality Improvement Program - Pediatrics database were obtained for patients <18 years undergoing clean ovarian surgery, including salpingo-oophorectomy (USO), ovarian sparing surgery (OSS), and oophorectomy, from 2021-2023 and supplemented with a detailed review of relevant patients at our institution. SSI rates were compared in those who did and did not receive SAP.
Among 2,137 ovarian surgeries, 50.5% received SAP. Patients undergoing open procedures were more likely to receive SAP than laparoscopic (69.1% vs 45.9%, p<0.001). Pediatric and adult general surgeons (64.8% and 64.9%) administered SAP more than gynecologists (24.2%, p<0.001). Overall SSI risk was 1.1% (n=24): 0.5% (n=5) with SAP and 1.8% with no-SAP (n=19, p=0.003). SSI rate was 1.9% in oophorectomy and 1.0% in OSS. On multivariable analysis, SAP was associated with decreased SSI (OR 0.24, 95% CI:0.08-0.62, p=0.006). SSI was associated with BMI >85th percentile (OR 3.20, 95% CI:1.41-10.3, p=0.038).
SAP administration in pediatric ovarian procedures is common and variable between specialties. Overall SSI risk is low, suggesting that while SAP administration is statistically significant in this analysis, it is not clinically significant. For patients with BMI >85^th percentile, SAP may be considered, but others are unlikely to significantly benefit.

PMID:
42586407
Bibliographic data and abstract were imported from PubMed on 13 Aug 2026.

Read full publication at:
Please sign in to see all details.

Stats

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.